Microbiome and chronic inflammatory bowel diseases (Q38781325)

6 September 2017

Microbiome and chronic inflammatory bowel diseases (English)

1 reference

inflammatory bowel diseases

6 September 2017

0 references

0 references

2

Julia-Stefanie Frick

0 references

author name string

Jan Wehkamp

series ordinal

1

1 reference

PubMed ID

27988792

6 September 2017

Julia-Stefanie Frick

series ordinal

2

1 reference

6 September 2017

17 December 2016

1 reference

Journal of Molecular Medicine

6 September 2017

1 reference

6 September 2017

95

1 reference

6 September 2017

1

1 reference

6 September 2017

21-28

1 reference

https://scigraph.springernature.com/pub.10.1007/s00109-016-1495-z

6 September 2017

0 references

cites work

Gut biogeography of the bacterial microbiota

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Host genetic variation impacts microbiome composition across human body sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Antibiotics, microbiota, and immune defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

A vegan or vegetarian diet substantially alters the human colonic faecal microbiota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Proton pump inhibitors alter the composition of the gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Structure and function of the healthy pre-adolescent pediatric gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Diversity of the human intestinal microbial flora

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Are We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Extensive Mobilome-Driven Genome Diversification in Mouse Gut-Associated Bacteroides vulgatus mpk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Evidence of extensive DNA transfer between bacteroidales species within the human gut

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Enterotypes of the human gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Complex glycan catabolism by the human gut microbiota: the Bacteroidetes Sus-like paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Prevotella enzymes involved in mucin oligosaccharide degradation and evidence for a small operon of genes expressed during growth on mucin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Human gut microbes impact host serum metabolome and insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

A metagenome-wide association study of gut microbiota in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Bacteroides vulgatus protects against Escherichia coli-induced colitis in gnotobiotic interleukin-2-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Intestinal colonization of IL-2 deficient mice with non-colitogenic B. vulgatus prevents DC maturation and T-cell polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Variation in Rural African Gut Microbiota Is Strongly Correlated with Colonization by Entamoeba and Subsistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Alterations in the gut microbiome of children with severe ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

A core gut microbiome in obese and lean twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Low counts of Faecalibacterium prausnitzii in colitis microbiota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

The gut microbiota and inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

A modular organization of the human intestinal mucosal microbiota and its association with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Antimicrobial peptides and gut microbiota in homeostasis and pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Innate immune functions of α-defensins in the small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Human -Defensin 6 Promotes Mucosal Innate Immunity Through Self-Assembled Peptide Nanonets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Paneth cell α-defensin 6 (HD-6) is an antimicrobial peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Carboxypeptidase A6 gene (CPA6) mutations in a recessive familial form of febrile seizures and temporal lobe epilepsy and in sporadic temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Paneth cells: maestros of the small intestinal crypts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Reduced Paneth cell alpha-defensins in ileal Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Crohn's disease-derived monocytes fail to induce Paneth cell defensins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Mammalian defensins in the antimicrobial immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

A microbial symbiosis factor prevents intestinal inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Intestinal microbiota in inflammatory bowel disease: friend of foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Lipopolysaccharide endotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Lipopolysaccharide heterogeneity: innate host responses to bacterial modification of lipid a structure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Elucidation of the structure of an alanine-lacking core tetrasaccharide trisphosphate from the lipopolysaccharide of Pseudomonas aeruginosa mutant H4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Structure and function: Lipid A modifications in commensals and pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

The atypical lipopolysaccharide of Francisella

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Fortifying the barrier: the impact of lipid A remodelling on bacterial pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

TLR signaling-induced CD103-expressing cells protect against intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Endotoxicity of lipopolysaccharide as a determinant of T-cell-mediated colitis induction in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Expression of a Porphyromonas gingivalis lipid A palmitylacyltransferase in Escherichia coli yields a chimeric lipid A with altered ability to stimulate interleukin-8 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Induction of human beta-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Duodenal infusion of donor feces for recurrent Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Weight gain after fecal microbiota transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Colitogenic and non-colitogenic commensal bacteria differentially trigger DC maturation and Th cell polarization: an important role for IL-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

Reduction of disulphide bonds unmasks potent antimicrobial activity of human β-defensin 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-016-1495-Z

The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection

21 January 2018

1 reference

12 December 2020

Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease

1 reference

12 December 2020

Lipopolysaccharide induces the rapid tyrosine phosphorylation of the mitogen-activated protein kinases erk-1 and p38 in cultured human vascular endothelial cells requiring the presence of soluble CD14.

1 reference

12 December 2020

Intestinal Microbiota and the Innate Immune System - A Crosstalk in Crohn's Disease Pathogenesis

1 reference

12 December 2020

IL-6 and maturation govern TLR2 and TLR4 induced TLR agonist tolerance and cross-tolerance in dendritic cells

1 reference

12 December 2020

Lipid A receptor TLR4-mediated signaling pathways

1 reference

12 December 2020

10.1007/S00109-016-1495-Z

Identifiers

DOI

1 reference

PubMed ID

27988792

Dimensions Publication ID

6 September 2017

0 references

1 reference

PubMed ID

27988792